Inventor · disambiguated record
Wilma Tamraz
Also filed as: TAMRAZ WILMA
6 granted patents·16 pending applications·22 citations·filing 2002–2022
80Inventor score
Top patents by PatentIndex Score
22 records- 0189US10682340B2Depot formulationsDURECT CORP·Filed 2017·Granted Jun 16, 2020·4 cites·19 claims
- 0289US9737605B2Injectable controlled release composition comprising high viscosity liquid carrierDURECT CORP·Filed 2014·Granted Aug 22, 2017·11 cites·23 claims
- 0384US10226532B2Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2017·Granted Mar 12, 2019·3 cites·20 claims
- 0481US9572812B2Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2016·Granted Feb 21, 2017·3 cites·20 claims
- 0580US10668011B2Depot formulationsDURECT CORP·Filed 2017·Granted Jun 2, 2020·1 cites·10 claims
- 0676US2022280646A1Compositions and methods involving polymer, solvent and high viscosity liquid carrier materialDURECT CORP·Filed 2022·Application pending·0 cites
- 0774US2020085829A1Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2019·Application pending·0 cites
- 0872US11285217B2Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2020·Granted Mar 29, 2022·0 cites·20 claims
- 0968US2018140605A1Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2018·Application pending·0 cites
- 1065US2017143721A1Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2017·Application pending·0 cites
- 1163US2019255179A1Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialDURECT CORP·Filed 2019·Application pending·0 cites
- 1259US2021169902A1Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesionsUNIV VIRGINIA COMMONWEALTH·Filed 2020·Application pending·0 cites
- 1358US2020383957A1Depot formulationsDURECT CORP·Filed 2020·Application pending·0 cites
- 1458US2020352852A1Depot formulationsDURECT CORP·Filed 2020·Application pending·0 cites
- 1558US2014171646A1Amorphous forms of palonosetron hydrochlorideHELSINN HEALTHCARE SA·Filed 2013·Application pending·0 cites
- 1656US2016214976A1Crystalline and amorphous forms of palonosetron hydrochlorideHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 1755US2019374554A1Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesionsUNIV VIRGINIA COMMONWEALTH·Filed 2017·Application pending·0 cites
- 1853US2014308352A1Compositions and methods involving polymer, solvent, and high viscosity liquid carrier materialZOGENIX INC·Filed 2014·Application pending·0 cites
- 1951US2019269695A1Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharideUNIV VIRGINIA COMMONWEALTH·Filed 2017·Application pending·0 cites
- 2045US2015291581A1Amorphous forms of palonosetron hydrochlorideHELSINN HEALTHCARE SA·Filed 2015·Application pending·0 cites
- 2144US2004102476A1High concentration formulations of opioids and opioid derivativesFiled 2002·Application pending·0 cites
- 2240US2011136847A1High Concentration Formulations of Opioids and Opioid DerivativesCHAN TAI WAH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →